Transcriptomic changes including p53 dysregulation prime DNMT3A mutant cells for transformation
Journal Title
EMBO Reports
Publication Type
Apr 30
Abstract
DNMT3A mutations are prevalent in haematologic malignancies. In our mouse model the murine homologue (R878H) of the human 'hotspot' R882H mutation is introduced into the mouse Dnmt3a locus. This results in globally reduced DNA methylation in all tissues. Mice with heterozygous R878H DNMT3A mutations develop γ-radiation induced thymic lymphoma more rapidly than control mice, suggesting a vulnerability to stress stimuli in Dnmt3a(R878H/+) cells. In competitive transplantations, Dnmt3a(R878H/+) Lin(-)Sca-1(+)Kit(+) (LSK) haematopoietic stem/progenitor cells (HSPCs) have a competitive advantage over WT HSPCs, indicating a self-renewal phenotype at the expense of differentiation. RNA sequencing of Dnmt3a(R878H/+) LSKs exposed to low dose γ-radiation shows downregulation of the p53 pathway compared to γ-irradiated WT LSKs. Accordingly, reduced PUMA expression is observed by flow cytometry in the bone marrow of γ-irradiated Dnmt3a(R878H/+) mice due to impaired p53 signalling. These findings provide new insights into how DNMT3A mutations cause subtle changes in the transcriptome of LSK cells which contribute to their increased self-renewal and propensity for malignant transformation.
Publisher
EMBO Press
Keywords
DNA Methylation; Dnmt3a; Epigenetics; Genetic Engineering; Haematological Cancers
Research Division(s)
Blood Cells And Blood Cancer; Bioinformatics and Computational Biology; Genetics and Gene Regulation; Ubiquitin Signalling
PubMed ID
40307617
Open Access at Publisher's Site
https://doi.org/10.1038/s44319-025-00450-4
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2025-05-06 09:11:24
Last Modified: 2025-05-06 09:11:51
An error has occurred. This application may no longer respond until reloaded. Reload 🗙